MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma

Published 2011 View Full Article

Authors

Keywords

Journal

NEURO-ONCOLOGY

Volume 12, Issue 2, Pages 116-121

Publisher

Oxford University Press (OUP)

Online

2011-11-19

DOI

10.1093/neuonc/nop020

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

NEURO-ONCOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Ask a Question. Answer a Question.